<!DOCTYPE html><html><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width, initial-scale=1"><link data-rh="true" rel="manifest" href="/manifest.json"/><link data-rh="true" rel="icon" sizes="16x16" href="/branding/favicon/16.png"/><link data-rh="true" rel="icon" sizes="24x24" href="/branding/favicon/24.png"/><link data-rh="true" rel="icon" sizes="32x32" href="/branding/favicon/32.png"/><link data-rh="true" rel="icon" sizes="64x64" href="/branding/favicon/64.png"/><link data-rh="true" rel="icon" sizes="128x128" href="/branding/favicon/128.png"/><link data-rh="true" rel="icon" sizes="256x256" href="/branding/favicon/256.png"/><link data-rh="true" rel="apple-touch-icon" href="/branding/apple-touch/ap-news-apple-touch-152.png"/><link data-rh="true" rel="apple-touch-icon" sizes="152x152" href="/branding/apple-touch/ap-news-apple-touch-152.png"/><link data-rh="true" rel="apple-touch-icon" sizes="180x180" href="/branding/apple-touch/ap-news-apple-touch-180.png"/><link data-rh="true" rel="apple-touch-icon" sizes="167x167" href="/branding/apple-touch/ap-news-apple-touch-167.png"/><link data-rh="true" rel="mask-icon" href="/branding/touch-bar-icon/ap-news-touch-bar.svg" color="#dedede"/><link data-rh="true" rel="search" href="/OpenSearchDescription.xml" title="AP News" type="application/opensearchdescription+xml"/><link data-rh="true" rel="stylesheet" type="text/css" href="https://cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.6.0/slick.min.css"/><meta data-rh="true" name="apple-mobile-web-app-capable" content="yes"/><meta data-rh="true" name="apple-mobile-web-app-status-bar-style" content="black"/><meta data-rh="true" name="theme-color" content="#dedede"/><meta data-rh="true" name="msapplication-config" content="browserconfig.xml"/><meta data-rh="true" name="description" content="NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa&#x27;s lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a... "/><meta data-rh="true" name="keywords" content="Health,Yale University,Virginia,Antibiotics,AP Top News,Science,U.S. News"/><meta data-rh="true" name="twitter:card" content="summary_large_image"/><meta data-rh="true" name="twitter:site" content="@ap"/><meta data-rh="true" property="twitter:title" content="Using 1 germ to fight another when today&#x27;s antibiotics fail"/><meta data-rh="true" property="twitter:description" content="NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa&#x27;s lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a... "/><meta data-rh="true" property="twitter:image" content="https://storage.googleapis.com/afs-prod/media/media:bb02511fe0ba40189a39b20e751ff49b/3000.jpeg"/><meta data-rh="true" property="twitter:url" content="https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0"/><meta data-rh="true" property="og:title" content="Using 1 germ to fight another when today&#x27;s antibiotics fail"/><meta data-rh="true" property="og:description" content="NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa&#x27;s lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a... "/><meta data-rh="true" property="og:type" content="article"/><meta data-rh="true" property="og:url" content="https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0"/><meta data-rh="true" property="og:image" content="https://storage.googleapis.com/afs-prod/media/media:bb02511fe0ba40189a39b20e751ff49b/3000.jpeg"/><meta data-rh="true" property="og:image:width" content="4500"/><meta data-rh="true" property="og:image:height" content="3000"/><meta data-rh="true" property="og:site_name" content="AP NEWS"/><meta data-rh="true" property="fb:app_id" content="870613919693099"/><meta data-rh="true" property="fb:pages" content="249655421622"/><meta data-rh="true" property="article:published_time" content="2019-02-26T16:45:01Z"/><meta data-rh="true" property="article:modified_time" content="2019-02-26T16:45:14Z"/><meta data-rh="true" property="article:section" content="Health"/><meta data-rh="true" property="article:tag" content="Health"/><meta data-rh="true" property="article:tag" content="Yale University"/><meta data-rh="true" property="article:tag" content="Virginia"/><meta data-rh="true" property="article:tag" content="Antibiotics"/><meta data-rh="true" property="article:tag" content="AP Top News"/><meta data-rh="true" property="article:tag" content="Science"/><meta data-rh="true" property="article:tag" content="U.S. News"/><script data-rh="true" type="application/ld+json">{"@context":"http://schema.org","@type":"NewsArticle","author":["Lauran Neergaard"],"dateModified":"2019-02-26T16:45:14Z","datePublished":"2019-02-26T16:45:01Z","description":"NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa's lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a... ","headline":"Using 1 germ to fight another when today's antibiotics fail","image":"https://storage.googleapis.com/afs-prod/media/media:bb02511fe0ba40189a39b20e751ff49b/2000.jpeg","mainEntityOfPage":{"@id":"https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0","@type":"WebPage"},"publisher":{"@type":"Organization","logo":{"@type":"ImageObject","height":60,"url":"http://apcontextual.appspot.com/Support/AMPLogo.png","width":600},"name":"Associated Press"}}</script><title data-rh="true">Using 1 germ to fight another when today&#x27;s antibiotics fail</title><meta name="google-site-verification" content="XvG-YKlyyPmG2x0J9-rdS-zI8LhL4d75ZQoccETD2qA"><link rel="stylesheet" type="text/css" href="/dist/index.css?hash=1717e085f3b"><style id="server-side-styles" type="text/css">.Component-ad-0-2-39 div {
  width: 100% !important;
  margin: 0 auto;
}
.Component-ad-0-2-39 div iframe {
  margin: 0 auto;
}
.Component-adTitle-0-2-40 {
  color: #9b9b9b;
  font-size: 0.75rem;
  margin-top: 0.625rem;
  text-align: center;
  font-family: 'GoodOT', Arial, sans-serif;
  font-weight: 300;
  line-height: 1rem;
}
.leaderboard-0-2-37 {
  height: 0;
  display: flex;
  padding: 0;
  overflow: hidden;
  position: relative;
  box-sizing: content-box;
  justify-content: center;
}
.dfpSlot-0-2-38 {
  position: absolute;
}
.Component-root-0-2-44 {
  width: 2rem;
  height: 2rem;
  display: block;
  font-size: 0;
}
.Component-root-0-2-45 {
  width: 2rem;
  height: 2rem;
  display: block;
  font-size: 0;
}
.Component-root-0-2-46 {
  width: 2rem;
  height: 2rem;
  display: block;
  font-size: 0;
}
.Component-root-0-2-47 {
  width: 2rem;
  cursor: pointer;
  height: 2rem;
  display: block;
  font-size: 0;
}
.Component-rootBig-0-2-48 {
  width: 8.25rem;
  overflow: hidden;
  position: relative;
}
.Component-message-0-2-49 {
  top: 0;
  left: 2rem;
  color: var(--colour, #777878);
  position: absolute;
  font-size: 0.875rem;
  font-family: 'GoodOT', Arial, sans-serif;
  font-weight: 300;
  line-height: 2rem;
}
.Component-area-0-2-50 {
  top: -1000000px;
  left: -1000000px;
  width: 10px;
  height: 10px;
  opacity: 0;
  position: fixed;
  pointer-events: none;
}
.Component-root-0-2-41 {
  width: 7rem;
  display: flex;
  --colour: #0a3175;
  flex-flow: row wrap;
  justify-content: space-between;
}
.Component-copyLink-0-2-42 {
  width: 100%;
  margin-top: 1.125rem;
}
.Component-oneLineDisplay-0-2-43 {
  width: 17.5rem;
  align-items: center;
}
.apLine-0-2-60 {
  width: 3.75rem;
  height: 0.5rem;
  background: #ff322e;
  transform-origin: left top;
}
.Component-title-0-2-51 {
  color: #787878;
  font-family: 'GoodOT', Arial, sans-serif;
  font-weight: 300;
  text-transform: uppercase;
}
.Component-headline-0-2-52, .Component-headline-0-2-52:link, .Component-headline-0-2-52:visited, .Component-headline-0-2-52:hover, .Component-headline-0-2-52:active {
  color: #2c2c2c;
  text-decoration: none;
}
.Component-h1-0-2-53 {
  left: -0.125rem;
  margin: 0;
  position: relative;
  font-size: 1.75rem;
  font-family: 'GoodOT-Cond', Arial Narrow, Arial, sans-serif;
  font-weight: 500;
}
.Component-root-0-2-59 {
  color: #828282;
}
.Component-signature-0-2-56 {
  left: -0.0625rem;
  margin: 0.5rem 0 1rem 0;
  display: inline-flex;
  position: relative;
  flex-flow: row wrap;
  font-family: 'GoodOT', Arial, sans-serif;
  font-weight: 300;
}
.Component-bylines-0-2-57 {
  padding-right: 1.375rem;
}
.Component-headline-0-2-54 {
  display: block;
}
.Component-headline-0-2-54, .Component-headline-0-2-54:link, .Component-headline-0-2-54:visited, .Component-headline-0-2-54:hover, .Component-headline-0-2-54:active {
  color: #2c2c2c;
  text-decoration: none;
}
.Component-h1-0-2-55 {
  left: -0.125rem;
  margin: 0;
  position: relative;
  font-size: 1.75rem;
  font-family: 'GoodOT-Cond', Arial Narrow, Arial, sans-serif;
  font-weight: 500;
}
.Component-root-0-2-69 {
  color: #787878;
  padding: 0.75rem;
  font-size: 0.875rem;
  background: #fff;
  font-family: 'GoodOT', Arial, sans-serif;
  font-weight: 300;
  pointer-events: none;
}
.Component-leadFeature-0-2-61 {
  overflow: hidden;
  position: relative;
  margin-bottom: 0.75rem;
}
.Component-leadFeature-0-2-61.LeadFeature_video .count-caption {
  display: none;
}
.Component-leadFeature-0-2-61:hover .count-caption {
  opacity: 1;
}
.Component-countCaption-0-2-62 {
  left: 0;
  width: 100%;
  bottom: 0;
  margin: 0;
  opacity: 0;
  padding: 5.75rem 0.75rem 0.75rem 0.75rem;
  position: absolute;
  transition: opacity 0.15s;
  background-clip: initial;
  background-size: initial;
  background-color: initial;
  background-image: linear-gradient(rgba(0, 0, 0, 0), rgba(0, 0, 0, 0.6));
  background-origin: initial;
  background-repeat-x: initial;
  background-repeat-y: initial;
  background-attachment: initial;
  background-position-x: initial;
  background-position-y: initial;
}
@media only screen and (max-width: 53.0625rem) {
  .Component-countCaption-0-2-62 {
    display: none;
  }
}
  .Component-visible-0-2-63 {
    opacity: 1;
  }
  .Component-hidden-0-2-64 {
    opacity: 0;
  }
  .Component-embedCaption-0-2-65 {
    color: #fff;
    background: transparent;
    font-family: 'GoodOT', Arial, sans-serif;
    font-weight: 300;
    line-height: 1.4;
  }
  .Component-galleryArrow-0-2-66 {
    top: 50%;
    right: 0.75rem;
    width: 2.5rem;
    cursor: pointer;
    height: 2.5rem;
    --colour: #fff;
    position: absolute;
    transform: translateY(-50%);
  }
  .Component-video-0-2-67 {
    pointer-events: none;
  }
  .Component-imageCaption-0-2-68 {
    overflow: auto;
    max-height: 10.625rem;
  }
  .Component-imageCaption-0-2-68::-webkit-scrollbar {
    width: 5px;
  }
  .Component-imageCaption-0-2-68::-webkit-scrollbar-track {
    box-shadow: inset 0 0 6px #727272;
  }
  .Component-imageCaption-0-2-68::-webkit-scrollbar-thumb {
    outline: 1px solid slategrey;
    background-color: darkgray;
  }
  .Component-root-0-2-78 {
    font-size: 1.125rem;
    font-family: 'FreightText', Georgia, serif;
    font-weight: 300;
    line-height: 1.6875rem;
  }
  .Component-root-0-2-78 a, .Component-root-0-2-78 a:link, .Component-root-0-2-78 a:visited, .Component-root-0-2-78 a:hover, .Component-root-0-2-78 a:active {
    color: #104ba5;
    text-decoration: none;
  }
  .Component-p-0-2-70 {
    margin: 0.75rem 0;
  }
@media only screen and (max-width: 47.9375rem) {
  .Component-p-0-2-70 {
    width: 100%;
  }
}
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-p-0-2-70 {
    width: 100%;
  }
}
@media only screen and (min-width: 64rem) {
  .Component-p-0-2-70 {
    width: 85.71428571428571%;
  }
}
  .Component-tallImage-0-2-71 {
    float: right;
    width: 42.857142857142854%;
    margin: 0 0 0.75rem 0.75rem;
  }
  .Component-image-0-2-72 {
    clear: right;
  }
  .Component-imageImg-0-2-73 {
    z-index: 1;
  }
  .Component-dfp-0-2-74 {
    clear: both;
    width: 100%;
    padding: 1.5rem 0;
    justify-content: left;
  }
  .Component-block-0-2-75 {
    margin: 0.75rem 0;
  }
  .Component-hubLink-0-2-76 {
    clear: both;
    margin: 0.75rem 0;
  }
  .Component-audioEmbed-0-2-77 {
    margin: 0.75rem 0;
  }
  .pianoArticle-0-2-79 .tp-container-inner {
    width: 100% !important;
  }
  .pianoArticle-0-2-79 .tp-container-inner iframe  {
    width: 100% !important;
  }
  .Component-list-0-2-26 {
    margin: 1.125rem 0 -1.5rem 0;
    display: inline-flex;
    padding: 0;
    flex-flow: wrap;
    list-style: none;
  }
  .Component-item-0-2-27 {
    margin-bottom: 1.5rem;
  }
  .Component-item-0-2-27:not(:last-child) {
    margin-right: 1.5rem;
  }
  .Component-icon-0-2-28 {
    width: 1.5625rem;
    height: 1.5625rem;
    display: block;
  }
  .Component-list-0-2-22 {
    margin: 1.5rem 0 -0.5rem 0;
  }
@media only screen and (max-width: 47.9375rem) {
  .Component-list-0-2-22 {
    display: flex;
    flex-flow: wrap;
  }
}
  .Component-item-0-2-23 {
    display: block;
    margin-bottom: 0.5rem;
  }
  .Component-item-0-2-23:not(:last-child) {
    margin-right: 0.5rem;
  }
  .Component-ios-0-2-24 {
    width: 8.125rem;
    height: 2.75rem;
  }
  .Component-android-0-2-25 {
    width: 9.375rem;
    height: 2.75rem;
  }
@media only screen and (min-width: 64rem) {
  .Component-legalStuff-0-2-29 {
    display: flex;
    padding: 0 0 6.25rem;
    flex-flow: row nowrap;
    justify-content: space-between;
  }
}
@media only screen and (max-width: 47.9375rem) {
  .Component-legalStuff-0-2-29 {
    padding: 0 0 2.375rem;
  }
}
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-legalStuff-0-2-29 {
    padding: 0 0 2.375rem;
  }
}
@media only screen and (min-width: 64rem) {
  .Component-legalStuffNav-0-2-30 {
    display: flex;
  }
}
  .Component-list-0-2-31 {
    margin: 0;
    display: flex;
    padding: 0;
    flex-wrap: wrap;
    list-style: none;
  }
  .Component-listItem-0-2-32 {
    padding-right: 0.75rem;
  }
  .Component-title-0-2-33 {
    font-size: 0.75rem;
    font-family: 'GoodOT', Arial, sans-serif;
    font-weight: 700;
    text-transform: uppercase;
  }
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-title-0-2-33 {
    padding: 1px 0.75rem 0 0;
  }
}
@media only screen and (min-width: 64rem) {
  .Component-title-0-2-33 {
    padding: 1px 0.75rem 0 0;
  }
}
@media only screen and (min-width: 64rem) {
  .Component-copyright-0-2-34 {
    text-align: center;
  }
}
@media only screen and (max-width: 47.9375rem) {
  .Component-span-0-2-35 {
    display: block;
  }
}
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-span-0-2-35 {
    display: block;
  }
}
@media only screen and (max-width: 47.9375rem) {
  .Component-spaceBelow-0-2-36 {
    margin-bottom: 0.5rem;
  }
}
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-spaceBelow-0-2-36 {
    margin-bottom: 0.5rem;
  }
}
  .Component-divider-0-2-21 {
    width: 100%;
    height: 1px;
    background: rgba(236, 236, 236, 0.19999999999999996);
  }
@media only screen and (min-width: 64rem) {
  .Component-divider-0-2-21 {
    margin: 2.25rem 0 1.75rem 0;
  }
}
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-divider-0-2-21 {
    margin: 1.5rem 0 1.25rem 0;
  }
}
@media only screen and (max-width: 47.9375rem) {
  .Component-divider-0-2-21 {
    margin: 1.125rem 0 0.75rem 0;
  }
}
  .Component-footer-0-2-10 {
    color: #fff;
    padding: 2.1875rem 0 0 0;
    font-size: 0.75rem;
    background: #2c2c2c;
    font-family: 'GoodOT', Arial, sans-serif;
    font-weight: 300;
  }
  .Component-footer-0-2-10 a, .Component-footer-0-2-10 a:link, .Component-footer-0-2-10 a:visited, .Component-footer-0-2-10 a:hover, .Component-footer-0-2-10 a:active {
    text-decoration: none;
  }
@media only screen and (min-width: 48rem) and (max-width: 63.9375rem) {
  .Component-grid-0-2-11 {
    display: grid;
    grid-template-rows: auto 1.875rem auto auto auto;
    grid-template-areas: "nav nav nav . . . apps apps apps . ." ". . . . . . . . . . ." "moreFromAp moreFromAp moreFromAp . . . followAp followAp followAp . ." "divider divider divider divider divider divider divider divider divider divider divider" "legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff";
    grid-template-columns: repeat(5, 4.8125rem 1fr) 4.8125rem;
  }
}
@media only screen and (min-width: 64rem) {
  .Component-grid-0-2-11 {
    display: grid;
    grid-template-areas: "nav nav nav . . . apps apps apps . . . moreFromAp moreFromAp moreFromAp . . . followAp followAp followAp . ." "divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider divider" "legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff legalStuff";
    grid-template-columns: repeat(11, 4.8125rem 1fr) 4.8125rem;
  }
}
  .Component-nav-0-2-12 {
    grid-area: nav;
  }
  .Component-apps-0-2-13 {
    grid-area: apps;
  }
  .Component-moreFromAp-0-2-14 {
    grid-area: moreFromAp;
  }
  .Component-followAp-0-2-15 {
    grid-area: followAp;
  }
  .Component-divider-0-2-16 {
    grid-area: divider;
  }
  .Component-legalStuff-0-2-17 {
    grid-area: legalStuff;
  }
  .Component-title-0-2-18 {
    font-size: 1rem;
    font-family: 'GoodOT', Arial, sans-serif;
    font-weight: 700;
    text-transform: uppercase;
  }
@media only screen and (max-width: 47.9375rem) {
  .Component-title-0-2-18 {
    font-size: 0.875rem;
  }
}
  .Component-list-0-2-19 {
    margin: 0;
    padding: 0;
    list-style: none;
    line-height: 2;
  }
  .Component-downloadDescription-0-2-20 {
    padding-top: 0.3125rem;
  }
@keyframes keyframes-delayedScroll-0-2-1 {
  0% {
    overflow-y: hidden;
  }
  99% {
    overflow-y: hidden;
  }
  100% {
    overflow-y: auto;
  }
}
  .overlay-0-2-2 {
    left: 0;
    width: 100%;
    height: 100%;
    margin: 0;
    padding: 0;
    z-index: -1;
    position: fixed;
  }
  .topicsDropdown-0-2-3 {
    top: calc(var(--navigation-height) + var( --navigation-padding-bottom) + var(--navigation-padding-top));
    left: 0;
    z-index: 4;
    --height: 0;
    position: absolute;
    background: #ececec;
    box-shadow: 0 2px 3px 0 #b5b5b6;
    text-align: left;
  }
  .dropdownWrapper-0-2-4 {
    height: var(--height);
    overflow: hidden;
    max-height: calc(80vh - 100px);
    transition: height 0.2s;
  }
  .dropdownWrapper-0-2-4.opened {
    animation: keyframes-delayedScroll-0-2-1 0.2s forwards;
    overflow-y: auto;
  }
  .dropdown-0-2-5 {
    margin: 0;
    padding: 1.125rem 1.5rem;
    font-size: 1rem;
    font-family: 'GoodOT', Arial, sans-serif;
    font-weight: 500;
    line-height: 2rem;
  }
  .dropdown-0-2-5, .dropdown-0-2-5:link, .dropdown-0-2-5:visited, .dropdown-0-2-5:hover, .dropdown-0-2-5:active {
    text-decoration: none;
  }
  .dropdownItem-0-2-6 {
    list-style: none;
  }
  .Component-button-0-2-7 {
    top: 1rem;
    right: var(--fluid-wrapper-padding);
    width: auto;
    border: 0;
    cursor: pointer;
    display: inline-block;
    outline: none;
    padding: 0 1rem;
    position: absolute;
    font-size: 1rem;
    background: #104ba5;
    text-align: left;
    font-family: 'GoodOT', Arial, sans-serif;
    font-weight: 300;
    line-height: 2rem;
  }
  .Component-button-0-2-7, .Component-button-0-2-7:link, .Component-button-0-2-7:visited, .Component-button-0-2-7:hover, .Component-button-0-2-7:active {
    color: white;
    text-decoration: none;
  }
@media only screen and (max-width: 47.9375rem) {
  .Component-button-0-2-7 {
    top: 0;
  }
}
  .Component-loader-0-2-8 {
    display: none;
    --colour: white;
    margin-left: 6px;
  }
  .Component-loader-0-2-8 .sk-fading-circle {
    width: 1rem;
    height: 1rem;
  }
  .Component-loader-0-2-8.searching {
    display: inline-block;
  }
  .Component-arrow-0-2-9 {
    width: 0.78125rem;
    height: 0.78125rem;
    display: inline;
    margin-left: 0.625rem;
  }
  .Component-arrow-0-2-9.searching {
    display: none;
  }</style></head><body><div id="root"><div class="App" data-reactroot=""><noscript style="display:none;visibility:hidden"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WNXLD4" width="0" height="0" title="Google Tag Manager iframe"></iframe></noscript><noscript style="display:none;visibility:hidden"><img src="https://sb.scorecardresearch.com/p?c1=2&amp;c2=3005041&amp;cv=2.0&amp;cj=1" alt="Comscore beacon"/></noscript><main class="Main"><div class="Header" style="height:97px;top:0"><div class="fluid-wrapper"><a class="header-logo" href="/"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-logo"></use></svg></a><div class="optional-header-title hub" style="opacity:0"></div><div class="header-title" style="height:48px;padding-top:17px"><div class="title">AP NEWS</div></div><nav class="header-navigation-wrapper"><ol class="header-navigation"><li class="header-navigation-item"><a class="nav-action" href="/">Top Stories</a></li><li class="header-navigation-item topics"><label class="nav-action">Topics<svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-down-arrow"></use></svg></label><nav class="topicsDropdown-0-2-3 TopicsDropdown" style="right:auto"><div class="dropdown-wrapper dropdownWrapper-0-2-4" style="--height:0"><ol class="dropdown-0-2-5 dropdown"></ol></div></nav></li><li class="header-navigation-item"><a class="nav-action" href="/apf-videos">Video</a></li><li class="header-navigation-item radio"><span class="nav-action">Listen</span><div class="Radio" style="height:0;width:0"><div class="radio-content"><audio class="radio-player"></audio><div class="radio-text"><div class="radio-title">AP RADIO</div><div class="radio-subtitle">Update hourly</div></div><div class="radio-control radio-play"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-play"></use></svg></div></div></div></li><li class="header-navigation-item search"><div class="nav-action"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-search"></use></svg></div></li></ol></nav></div><div class="search-wrapper"><div class="SearchPopover" style="--height:0"><div class="inner"><input class="input" placeholder="Search" value=""/><button class="Component-button-0-2-7"><span>Search</span><div class="Loader Component-loader-0-2-8"><div class="sk-fading-circle"><div class="sk-circle1 sk-circle"></div><div class="sk-circle2 sk-circle"></div><div class="sk-circle3 sk-circle"></div><div class="sk-circle4 sk-circle"></div><div class="sk-circle5 sk-circle"></div><div class="sk-circle6 sk-circle"></div><div class="sk-circle7 sk-circle"></div><div class="sk-circle8 sk-circle"></div><div class="sk-circle9 sk-circle"></div><div class="sk-circle10 sk-circle"></div><div class="sk-circle11 sk-circle"></div><div class="sk-circle12 sk-circle"></div></div></div><svg class="SvgSprite Component-arrow-0-2-9"><use xlink:href="/dist/spritemap.svg#sprite-arrow"></use></svg></button><section class="search-results"></section></div></div></div></div><div class="header-placeholder"></div><div class="Body"><div class="Content WireStory fluid-wrapper with-lead"><div class="Leaderboard leaderboard-0-2-37"><div class="dfpSlot-0-2-38"><div data-key="ad-placeholder" id="div-gpt-ad-1461247613791-X" class="DFPSlot Component-ad-0-2-39"></div></div></div><div class="SocialShare Component-root-0-2-41 tablet-view"><a href="https://facebook.com/dialog/share?app_id=870613919693099&amp;display=popup&amp;href=https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0" target="_blank" rel="noopener noreferrer" class="Component-root-0-2-44"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-facebook"></use></svg></a><a href="https://twitter.com/intent/tweet?url=https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0" target="_blank" rel="noopener noreferrer" class="Component-root-0-2-45"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-twitter"></use></svg></a><a href="mailto:?subject=Using 1 germ to fight another when today&#x27;s antibiotics fail&amp;body=https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0" class="Component-root-0-2-46"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-email"></use></svg></a><div class="Component-root-0-2-47 Component-copyLink-0-2-42 Component-rootBig-0-2-48"><textarea tabindex="-1" class="Component-area-0-2-50">https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0</textarea><div class="Component-message-0-2-49">Click to copy</div><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-link"></use></svg></div></div><div class="ContentView-LeftRail"><div></div><div class="sticky-part"><div class="SocialShare Component-root-0-2-41"><a href="https://facebook.com/dialog/share?app_id=870613919693099&amp;display=popup&amp;href=https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0" target="_blank" rel="noopener noreferrer" class="Component-root-0-2-44"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-facebook"></use></svg></a><a href="https://twitter.com/intent/tweet?url=https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0" target="_blank" rel="noopener noreferrer" class="Component-root-0-2-45"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-twitter"></use></svg></a><a href="mailto:?subject=Using 1 germ to fight another when today&#x27;s antibiotics fail&amp;body=https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0" class="Component-root-0-2-46"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-email"></use></svg></a><div class="Component-root-0-2-47 Component-copyLink-0-2-42 Component-rootBig-0-2-48"><textarea tabindex="-1" class="Component-area-0-2-50">https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0</textarea><div class="Component-message-0-2-49">Click to copy</div><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-share-link"></use></svg></div></div><div class="RelatedTopics"><div class="heading">Related topics</div><ul class="tag-list"><li class="tag"><a data-key="related-tag" href="/apf-Health">Health</a></li><li class="tag"><a data-key="related-tag" href="/YaleUniversity">Yale University</a></li><li class="tag"><a data-key="related-tag" href="/Virginia">Virginia</a></li><li class="tag"><a data-key="related-tag" href="/Antibiotics">Antibiotics</a></li><li class="tag"><a data-key="related-tag" href="/apf-topnews">AP Top News</a></li><li class="tag"><a data-key="related-tag" href="/apf-science">Science</a></li><li class="tag"><a data-key="related-tag" href="/apf-usnews">U.S. News</a></li></ul></div></div></div><div class="CardHeadline"><div class="Component-headline-0-2-54" data-key="card-headline"><h1 class="Component-h1-0-2-55">Using 1 germ to fight another when today’s antibiotics fail</h1></div><div class="Component-signature-0-2-56"><span class="Component-bylines-0-2-57">By LAURAN NEERGAARD</span><span class="Timestamp Component-root-0-2-59 Component-timestamp-0-2-58" data-key="timestamp" data-source="2019-02-26T16:45:14Z" title="2019-02-26 16:45:14 - Tue Feb 26 2019 16:45:14 GMT+0000 (Coordinated Universal Time)">February 26, 2019 GMT</span></div><div class="apLine-0-2-60" style="transform:scale(1)"></div></div><div class="divider"></div><a class="LeadFeature Component-leadFeature-0-2-61 LeadFeature_gallery" href="/b4c7e8aace4d45bca6d4b2f6b2ee0ac0/gallery/media:bb02511fe0ba40189a39b20e751ff49b"><div data-key="media-placeholder"></div><svg class="SvgSprite gallery-arrow Component-galleryArrow-0-2-66"><use xlink:href="/dist/spritemap.svg#sprite-gallery-arrow"></use></svg><div class="count-caption Component-countCaption-0-2-62 ssr-desktop"><div class="ImageGalleryCount"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-gallery-count"></use></svg><span>1 of 10</span></div><div class="Component-imageCaption-0-2-68"><div class="embed-caption Component-root-0-2-69 Component-embedCaption-0-2-65" data-key="embed-caption">Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and antibiotic-resistant bacteria lodged inside her CF-damaged lungs, watches as Yale University researcher Benjamin Chan, pours a bacteriophagen he developed for her to inhale, at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)</div></div></div><div class="count-caption Component-countCaption-0-2-62 ssr-tablet"><div class="ImageGalleryCount"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-gallery-count"></use></svg><span>1 of 10</span></div><div class="Component-imageCaption-0-2-68"><div class="embed-caption Component-root-0-2-69 Component-embedCaption-0-2-65" data-key="embed-caption">Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and antibiotic-resistant bacteria lodged inside her CF-damaged lungs, watches as Yale University researcher Benjamin Chan, pours a bacteriophagen he developed for her to inhale, at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)</div></div></div></a><div class="Article" data-key="article"><p class="Component-root-0-2-78 Component-p-0-2-70">NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa’s lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a virus culled from sewage to attack her superbug.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“I’m really running out of options,” said Balasa, who traveled from her Richmond, Virginia, home to Yale University for the last-resort treatment. “I know it might not have an effect. But I am very hopeful.”</p><p class="Component-root-0-2-78 Component-p-0-2-70">Pitting one germ against another may sound radical, but it’s a sign of a growing global crisis. Increasingly people are dying of infections that once were easy to treat because many common bugs have evolved to withstand multiple antibiotics. Some, dubbed “nightmare bacteria,” are untreatable. Now scientists are racing to find novel alternatives to traditional antibiotics, a hunt that is uncovering unusual ways to counter infection, in unusual places.</p><div class="Component-dfp-0-2-74"><div data-key="ad-placeholder" id="div-gpt-ad-1470255291270-0" class="DFPSlot Component-ad-0-2-39"></div></div><p class="Component-root-0-2-78 Component-p-0-2-70">One possible treatment tricks bacteria out of a nutrient they need to survive. Others rev up the immune system to better fend off germs.</p><p class="Component-root-0-2-78 Component-p-0-2-70">And viruses called bacteriophages — discovered a century ago but largely shelved in the West when easier-to-use antibiotics came along — are being tried in a handful of emergency cases.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“People’s frustration with antibiotic resistance boiled over,” said Yale biologist Benjamin Chan, who travels the world collecting phages and receives calls from desperate patients asking to try them. “We’re more appreciative of the fact that we need alternatives.”</p><div data-key="media-placeholder"><div class="YoutubeEmbed youtubeEmbed"><div class="vertical-wrapper"><div class="vertical-limit"></div><img alt="ratio" class="ratio" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABAAAAAJCAAAAAAeQfPuAAAAC0lEQVQYGWMYrAAAAJkAAWzZLOIAAAAASUVORK5CIIA="/></div><div class="horizontal-limit"></div><div class="youtube-player" id="youtube-wrapper-an9CTHD4fvE-article"><img class="thumbnail" src="https://img.youtube.com/vi/an9CTHD4fvE/0.jpg" alt="Youtube video thumbnail"/></div></div></div><p class="Component-root-0-2-78 Component-p-0-2-70">Nature’s bacterial predator, each phage variety targets a different bacterial strain. Originally used to treat dysentery in the early 20th century, today Chan looks in places like ditches, ponds, and, yes, sewage treatment plants for types that attack a variety of human infections.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“The best places are often really dirty places, because we’re dirty animals,” he said.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Chan saw hope for Balasa in a lab dish covered in brownish bacterial goo.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Balasa has a genetic disease called cystic fibrosis that scars her lungs and traps bacteria inside, including a superbug named Pseudomonas aeruginosa. A daily dose of inhaled antibiotics kept the infection in check until last fall, when the drugs quit working. A last-ditch IV antibiotic wasn’t helping much either.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Chan grew a sample of Balasa’s bacteria from her phlegm. Then came the key test: He dripped several pseudomonas-targeting phages into the grimy dish — and clear circles began appearing as the viruses consumed the bugs around them.</p><div class="Component-dfp-0-2-74"><div data-key="ad-placeholder" id="div-gpt-ad-1470255291270-1" class="DFPSlot Component-ad-0-2-39"></div></div><p class="Component-root-0-2-78 Component-p-0-2-70">But would what worked in the lab really help Balasa’s lungs?</p><div class="Component-image-0-2-72" data-key="media-placeholder"></div><p class="Component-root-0-2-78 Component-p-0-2-70">BUGS OUTPACING DRUGS</p><p class="Component-root-0-2-78 Component-p-0-2-70">At least 23,000 Americans die every year as a direct result of an antibiotic-resistant infection, and many more die from related complications, according to a 2013 report from the Centers for Disease Control and Prevention. The CDC plans an updated count, but other research has estimated the toll could be seven times higher.</p><p class="Component-root-0-2-78 Component-p-0-2-70">And while there are no good counts in much of the world, one often-cited British report said unless solutions are found, by 2050 up to 10 million people globally could be dying from drug-resistant infections, slightly more than die from cancer today.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Yet few new antibiotics make it to market, and many major drug companies have ended antibiotic research, seeing little profit in medicines that germs will soon outsmart. A recent report found just 11 traditional antibiotics being studied to treat any of the World Health Organization’s list of worst bugs, with no guarantee they’ll work.</p><p class="Component-root-0-2-78 Component-p-0-2-70">And while some people are more at risk — those getting surgery, or cancer chemotherapy, for example — “antibiotic resistance is a problem essentially for everyone,” said Dr. Anthony Fauci, infectious diseases chief at the National Institutes of Health.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“Over the next several years, all indicators seem to point to the fact that this is going to get worse and worse,” he added.</p><p class="Component-root-0-2-78 Component-p-0-2-70">LOOKING FOR BUGS’ WEAK SPOTS</p><p class="Component-root-0-2-78 Component-p-0-2-70">Finding alternatives means “figuring out what the vulnerabilities of infecting bacteria are. What do they need to cause an infection?” said Dr. Pradeep Singh of the University of Washington.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Singh and fellow UW lung specialist Dr. Christopher Goss zeroed in on iron, a nutrient vital for bacterial growth. It turns out that bugs can’t always tell the difference between iron and a chemically similar metal named gallium. Gallium doesn’t nourish and knocks other systems out of whack, Goss said.</p><p class="Component-root-0-2-78 Component-p-0-2-70">For two small studies, the researchers recruited cystic fibrosis patients who had antibiotic-resistant pseudomonas in their lungs but weren’t openly sick. The patients received a five-day infusion of a gallium-based drug. Over the next few weeks, their lung function improved, enough that next-step studies are being planned.</p><div class="Component-image-0-2-72" data-key="media-placeholder"></div><p class="Component-root-0-2-78 Component-p-0-2-70">“It just seems like a proactive way of destroying bacteria,” said study participant Tre LaRosa, 24, of Cincinnati. His sister died of cystic fibrosis and while his own CF is under control, he worries that one day a resistant infection will flare. “I can’t do anything to prevent that. Antibiotic resistance I think is one of the least talked about and most significant concerns.”</p><p class="Component-root-0-2-78 Component-p-0-2-70">SPURRING THE IMMUNE SYSTEM</p><p class="Component-root-0-2-78 Component-p-0-2-70">Fauci envisions doctors one day vaccinating people a few weeks before, say, a planned knee replacement to guard against catching a staph infection in the hospital.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Sixteen experimental vaccines are in development to target various infections, according to a recent presentation to a presidential advisory council on resistant germs.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Particularly promising, Fauci says, are lab-engineered “monoclonal antibodies” designed to home in on specific bugs. In one set of studies, researchers are giving experimental antibodies to ventilator patients who have bacteria building up that could trigger pneumonia.</p><p class="Component-root-0-2-78 Component-p-0-2-70">HARNESSING VIRUSES FOR THE BEST ATTACK</p><p class="Component-root-0-2-78 Component-p-0-2-70">In Virginia, Balasa learned of another cystic fibrosis patient helped by Yale’s phage experiments and asked to try, hoping to postpone the last option for CF, a lung transplant.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Phages work very differently than traditional antibiotics. Like a parasite, the virus infiltrates bacterial cells and uses them to copy itself, killing the bug as those copies pop out and search for more bacteria. Once the infection’s gone, the virus dies out. Because each phage only recognizes certain bacteria, it shouldn’t kill off “good bugs” in the digestive tract like antibiotics do.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Bacteria evolve to escape phages just like they escape antibiotics, but they generally make trade-offs to do so — such as losing some of their antibiotic resistance, said Yale evolutionary biologist Paul Turner.</p><div class="Component-image-0-2-72" data-key="media-placeholder"></div><p class="Component-root-0-2-78 Component-p-0-2-70">For example, some phages recognize bacteria by a pump on their surface that deflects antibiotics. As the phages kill those bugs, the bacteria rapidly evolve to get rid of that surface pump — meaning survivors should be susceptible to antibiotics again.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“It’s reviving an arsenal of drugs that are no longer useful,” Turner said.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Yale’s first test case was an 82-year-old man near death from a heart implant teeming with untreatable pseudomonas. Chan purified a phage from a Connecticut lake that he’d matched to the patient’s germs, and with emergency permission from the Food and Drug Administration, doctors squirted it into the wound. The man’s infection disappeared.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Then doctors at the University of California, San Diego, saved a colleague who’d been in a months-long coma, using an IV mixture of several phages that target a superbug named Acinetobacter baumannii.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Doctors and families began calling both centers seeking emergency care, even as formal studies are being planned to try to prove phages’ value.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“There’s an incredible opportunity here,” said Yale pulmonologist Dr. Jon Koff. “But with that you have to have the appropriate amount of skepticism,” with careful testing to tell when it might help.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Last month, Balasa became Yale’s eighth patient, inhaling billions of phages over seven days.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Almost immediately, she was coughing up fewer bacteria. It took a few weeks for her to feel better, though, and during that time she switched briefly to some antibiotics she’d previously given up. Without a formal study it’s hard to know, but Chan’s tests suggest phages killed much of her predominant pseudomonas strain and made the survivors sensitive again to a course of those antibiotics.</p><p class="Component-root-0-2-78 Component-p-0-2-70">Balasa called that “a very big success for me,” and was able to quit her antibiotics. She didn’t notice additional improvement after a second round of phages, aimed at different strains.</p><p class="Component-root-0-2-78 Component-p-0-2-70">“The true test,” Balasa said, “is how long I can go without using any antibiotics again.”</p><p class="Component-root-0-2-78 Component-p-0-2-70">___</p><p class="Component-root-0-2-78 Component-p-0-2-70">The Associated Press Health &amp; Science Department receives <a href="http://bit.ly/2G0n9w6" target="_blank" rel="noopener noreferrer" class="">support</a><!-- --> from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.</p></div><aside class="RightRail"><div><div data-key="ad-placeholder" id="div-gpt-ad-1461247613791-2" class="DFPSlot Component-ad-0-2-39"></div></div><div id="taboola-right-rail-thumbnails" class="top-stories"></div><div class="persistent-ad"><div><div data-key="ad-placeholder" id="div-gpt-ad-1461247613791-1" class="DFPSlot Component-ad-0-2-39"></div></div></div></aside><div class="bellow-article"><div class="piano-below-article-container pianoArticle-0-2-79"></div><div><div id="Below Article Thumbnails - V2.0"></div></div><div><div data-key="ad-placeholder" id="div-gpt-ad-1470255291270-X" class="DFPSlot Component-ad-0-2-39"></div></div></div></div></div><div class="Component-footer-0-2-10"><div class="fluid-wrapper"><div class="Component-grid-0-2-11"><nav class="Component-nav-0-2-12"><div class="Component-title-0-2-18">AP NEWS</div><ol class="Component-list-0-2-19"><li><a href="/">Top Stories</a></li><li><a href="/apf-videos">Video</a></li><li><a href="mailto:support@apnews.com" rel="noopener noreferrer">Contact Us</a></li><li><a class="optanon-show-settings">Cookie Settings</a></li></ol></nav><div class="ssr-mobile Component-divider-0-2-21"></div><nav class="Component-apps-0-2-13"><div class="Component-title-0-2-18">Download AP NEWS</div><div class="Component-downloadDescription-0-2-20">Connect with the definitive source for global and local news</div><div class="Component-list-0-2-22"><a href="https://itunes.apple.com/us/app/ap-news/id364677107" target="_blank" rel="noopener noreferrer" class="Component-item-0-2-23 Component-ios-0-2-24"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-app-store"></use></svg></a><a href="https://play.google.com/store/apps/details?id=mnn.Android" target="_blank" rel="noopener noreferrer" class="Component-item-0-2-23 Component-android-0-2-25"><img src="/en_badge_web_generic.png" class="SvgSprite" alt="Google Play icon"/></a></div></nav><div class="ssr-mobile Component-divider-0-2-21"></div><nav class="Component-moreFromAp-0-2-14"><div class="Component-title-0-2-18">More from AP</div><ol class="Component-list-0-2-19"><li><a target="_blank" rel="noopener noreferrer" href="https://www.ap.org">ap.org</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://insights.ap.org/">AP Insights</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://blog.ap.org/">AP Definitive Source</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://apimagesblog.com/">AP Images Spotlight</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://www.ap.org/explore/">AP Explore</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://www.ap.org/books/">AP Books</a></li></ol></nav><div class="ssr-mobile Component-divider-0-2-21"></div><nav class="Component-followAp-0-2-15"><div class="Component-title-0-2-18">Follow AP</div><ol class="Component-list-0-2-26"><li class="Component-item-0-2-27"><a target="_blank" rel="noopener noreferrer" href="https://twitter.com/AP" class="Component-icon-0-2-28"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-social-twitter"></use></svg></a></li><li class="Component-item-0-2-27"><a target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/APNews" class="Component-icon-0-2-28"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-social-facebook"></use></svg></a></li><li class="Component-item-0-2-27"><a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/user/AssociatedPress" class="Component-icon-0-2-28"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-social-youtube"></use></svg></a></li><li class="Component-item-0-2-27"><a target="_blank" rel="noopener noreferrer" href="https://www.linkedin.com/company/associated-press" class="Component-icon-0-2-28"><svg class="SvgSprite"><use xlink:href="/dist/spritemap.svg#sprite-social-linkedin"></use></svg></a></li></ol></nav><div class="Component-divider-0-2-16 Component-divider-0-2-21"></div><div class="Component-legalStuff-0-2-17 Component-legalStuff-0-2-29"><nav class="Component-legalStuffNav-0-2-30"><div class="Component-title-0-2-33 Component-spaceBelow-0-2-36">The Associated Press</div><ol class="Component-list-0-2-31"><li class="Component-listItem-0-2-32 Component-spaceBelow-0-2-36"><a target="_blank" rel="noopener noreferrer" href="https://www.ap.org/about">About</a></li><li class="Component-listItem-0-2-32 Component-spaceBelow-0-2-36"><a target="_blank" rel="noopener noreferrer" href="https://www.ap.org/contact-us">Contact</a></li><li class="Component-listItem-0-2-32 Component-spaceBelow-0-2-36"><a target="_blank" rel="noopener noreferrer" href="http://aphelp.ap.org">Customer Support</a></li><li class="Component-listItem-0-2-32 Component-spaceBelow-0-2-36"><a target="_blank" rel="noopener noreferrer" href="https://www.ap.org/careers/">Careers</a></li><li class="Component-listItem-0-2-32 Component-spaceBelow-0-2-36"><a href="/termsofservice">Terms &amp; Conditions</a></li><li class="Component-listItem-0-2-32 Component-spaceBelow-0-2-36"><a href="/privacystatement">Privacy</a></li></ol></nav><div class="Component-copyright-0-2-34"><span class="Component-span-0-2-35 Component-spaceBelow-0-2-36">All contents © copyright <!-- -->2020<!-- --> The Associated Press.</span><span class="Component-span-0-2-35 Component-spaceBelow-0-2-36"> All rights reserved.</span></div></div></div></div></div></main></div></div><script>window['titanium-config'] = {"env":"prod","base":"https://apnews.com","afsApi":"https://afs-prod.appspot.com/api/v2","gcsRoot":"https://storage.googleapis.com/afs-prod","googleAnalyticsId":"UA-19104461-33","googleTagManagerId":"GTM-WNXLD4","dfpEnvironment":"PRODUCTION","appVersion":"181","pianoAid":"wwB5UljV1U","appNexus":"https://acdn.adnxs.com/prebid/c/7403/pb.js"};
window['titanium-state'] = {"eyebrow":{"loading":{},"error":{},"data":{},"loadedAt":{},"expiration":120000},"markdown":{"loading":{},"error":{},"data":{},"loadedAt":{},"expiration":600000},"hub":{"loading":{},"error":{},"data":{},"loadedAt":{},"expiration":120000},"card":{"loading":{},"error":{},"data":{},"loadedAt":{},"expiration":120000},"content":{"loading":{"urn:publicid:ap.org:b4c7e8aace4d45bca6d4b2f6b2ee0ac0":false},"error":{"urn:publicid:ap.org:b4c7e8aace4d45bca6d4b2f6b2ee0ac0":null},"data":{"urn:publicid:ap.org:b4c7e8aace4d45bca6d4b2f6b2ee0ac0":{"block_fundamentals":true,"embedHTML":null,"embedHeight":null,"stackedStory":true,"contentSponsor":null,"embedType":"Other","tagObjs":[{"id":"apf-Health","name":"Health","order":1},{"id":"YaleUniversity","name":"Yale University","order":0},{"id":"Virginia","name":"Virginia","order":0},{"id":"Antibiotics","name":"Antibiotics","order":0},{"id":"apf-topnews","name":"AP Top News","order":7},{"id":"apf-science","name":"Science","order":1},{"id":"apf-usnews","name":"U.S. News","order":2}],"pullQuoteObjs":[],"sequenceNumber":0,"title":"US-MED--Antibiotic Alternatives","headline":"Using 1 germ to fight another when today's antibiotics fail","localMemberName":null,"dateline":"NEW HAVEN, Conn.","truncatedFirstWords":true,"notificationId":null,"mediaCount":10,"contentType":"text","embedRatio":null,"shortId":"b4c7e8aace4d45bca6d4b2f6b2ee0ac0","localLinkUrl":"https://apnews.com/b4c7e8aace4d45bca6d4b2f6b2ee0ac0","interactiveLinkUrl":null,"mediumIds":["media:bb02511fe0ba40189a39b20e751ff49b","media:08e2f0afebd040e5a9d0eb96873c1180","media:fddef52f13b744f9b4ae5dadace6d67e","media:9a5dfb0813a345038de93821b32c20fc","media:daf57a871b0e4a21a5fde69cc8056261","media:5065213a8fae4509a0ed6e01c539b822","media:5916930e12b1460bb883618f2fd3bbc4","media:70e4faff246640a98a71f1962b96aa26","media:3fda999eb2db4bfa8af4d61c7723c320","media:8e655b0b1e0d4bed94ca6acb32b92d45"],"alertLinkDateTime":null,"layoutType":"Small Photo","contexts":null,"updated":"2019-02-26 16:45:14","flattenedFirstWords":"NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa's lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a...","id":"urn:publicid:ap.org:b4c7e8aace4d45bca6d4b2f6b2ee0ac0","embedCaption":null,"media":[{"altText":"Ella Balasa, Benjamin Chan","imageFileExtension":".jpeg","id":"media:bb02511fe0ba40189a39b20e751ff49b","embedCaption":"Ella Balasa watches Benjamin Chan pour a bacteriophagen he developed for her to inhale at the Winchester Chest Clinic in Connecticut. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and antibiotic-resistant bacteria lodged inside her CF-damaged lungs, watches as Yale University researcher Benjamin Chan, pours a bacteriophagen he developed for her to inhale, at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and antibiotic-resistant bacteria lodged inside her CF-damaged lungs, watches as Yale University researcher Benjamin Chan, pours a bacteriophagen he developed for her to inhale, at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:bb02511fe0ba40189a39b20e751ff49b/"},{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:08e2f0afebd040e5a9d0eb96873c1180","embedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds a petri dish containing Pseudomonas aeruginosa lung samples. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds a petri dish containing Pseudomonas aeruginosa lung samples grown from patient Ella Balasa, at Osborne Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Pitting one germ against another may sound radical, but it’s a sign of a growing global crisis. Increasingly people are dying of infections that once were easy to treat, as common bacteria evolve to resist drugs that form the foundation of modern medicine. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds a petri dish containing Pseudomonas aeruginosa lung samples grown from patient Ella Balasa, at Osborne Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Pitting one germ against another may sound radical, but it&#8217;s a sign of a growing global crisis. Increasingly people are dying of infections that once were easy to treat, as common bacteria evolve to resist drugs that form the foundation of modern medicine. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:08e2f0afebd040e5a9d0eb96873c1180/"},{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:fddef52f13b744f9b4ae5dadace6d67e","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:fddef52f13b744f9b4ae5dadace6d67e/"},{"altText":null,"imageFileExtension":".jpeg","id":"media:9a5dfb0813a345038de93821b32c20fc","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, prepares an antibiotic injection at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, prepares an antibiotic injection at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:9a5dfb0813a345038de93821b32c20fc/"},{"altText":"Ella Balasa","imageFileExtension":".jpeg","id":"media:daf57a871b0e4a21a5fde69cc8056261","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Ella Balasa, 26, of Richmond, Va., pauses to cough as she inhales cystic fibrosis medications to help clear her airways, at Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Antibiotic-resistant bacteria are lodged inside her CF-damaged lungs. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Ella Balasa, 26, of Richmond, Va., pauses to cough as she inhales cystic fibrosis medications to help clear her airways, at Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Antibiotic-resistant bacteria are lodged inside her CF-damaged lungs. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:daf57a871b0e4a21a5fde69cc8056261/"},{"altText":"Jon Koff, Ella Balasa","imageFileExtension":".jpeg","id":"media:5065213a8fae4509a0ed6e01c539b822","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale pulmonary and critical care physician Dr. Jon Koff, talks with Ella Balasa, 26, of Richmond, Va., after her treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. She has cystic fibrosis, an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale pulmonary and critical care physician Dr. Jon Koff, talks with Ella Balasa, 26, of Richmond, Va., after her treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. She has cystic fibrosis, an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:5065213a8fae4509a0ed6e01c539b822/"},{"altText":"Jon Koff, Benjamin Chan, Ella Balasa","imageFileExtension":".jpeg","id":"media:5916930e12b1460bb883618f2fd3bbc4","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale pulmonary and critical care physician Dr. Jon Koff, left, and Yale University researcher Benjamin Chan, center, watch as Ella Balasa, 26, of Richmond, Va., inhales a bacteriophage, developed by Chan, during treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Balasa has cystic fibrosis and a superbug named Pseudomonas aeruginosa is trapped in her damaged lungs. Until last fall, a daily dose of inhaled antibiotics kept it in check but suddenly, the drugs quit working. A last-ditch IV antibiotic wasn't helping much either. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale pulmonary and critical care physician Dr. Jon Koff, left, and Yale University researcher Benjamin Chan, center, watch as Ella Balasa, 26, of Richmond, Va., inhales a bacteriophage, developed by Chan, during treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Balasa has cystic fibrosis and a superbug named Pseudomonas aeruginosa is trapped in her damaged lungs. Until last fall, a daily dose of inhaled antibiotics kept it in check but suddenly, the drugs quit working. A last-ditch IV antibiotic wasn't helping much either. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:5916930e12b1460bb883618f2fd3bbc4/"},{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:70e4faff246640a98a71f1962b96aa26","embedCaption":"Benjamin Chan prepares a petri dish with mucus from patient Balasa at Osborn Memorial Laboratories om Connecticut. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Chan, who travels the world collecting viruses called bacteriophages, receives calls from desperate patients asking to try them. \"We're more appreciative of the fact that we need alternatives.\" (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Chan, who travels the world collecting viruses called bacteriophages, receives calls from desperate patients asking to try them. \"We're more appreciative of the fact that we need alternatives.\" (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:70e4faff246640a98a71f1962b96aa26/"},{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:3fda999eb2db4bfa8af4d61c7723c320","embedCaption":"\t\nYale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds bacteriophage treatment for patient Ella Balasa. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds bacteriophage treatment for patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Bacteriophages were discovered a century ago but largely shelved when easier-to-use antibiotics came along. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds bacteriophage treatment for patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Bacteriophages were discovered a century ago but largely shelved when easier-to-use antibiotics came along. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:3fda999eb2db4bfa8af4d61c7723c320/"},{"altText":"Researchers race to find antibiotic alternatives","imageFileExtension":".jpeg","id":"media:8e655b0b1e0d4bed94ca6acb32b92d45","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":"an9CTHD4fvE","videoMimeType":"video/mp4","managementId":"b53db9947cc2498a82f46a3d3a043a20","state":null,"flattenedCaption":"Scientists are racing to find novel ways to treat infections when traditional antibiotics fail, and they’re developing unusual approaches such as pitting one germ against another, as bacteria rapidly evolve to resist today's best medicines. (Feb. 26)","videoFileExtension":".mp4","type":"YouTube","caption":"\n              \u003cp>\n              Scientists are racing to find novel ways to treat infections when traditional antibiotics fail, and they&#8217;re developing unusual approaches such as pitting one germ against another, as bacteria rapidly evolve to resist today's best medicines. (Feb. 26)\n            \u003c/p>\n            ","imageRenderedSizes":[400],"aspectRatio":1.3333333333333333,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:8e655b0b1e0d4bed94ca6acb32b92d45/"}],"old_lead_video_key":"media:8e655b0b1e0d4bed94ca6acb32b92d45","etag":null,"gcsUrl":"https://storage.googleapis.com/afs-prod/contents/urn:publicid:ap.org:b4c7e8aace4d45bca6d4b2f6b2ee0ac0","revision":3,"videoContext":"e being tried in a handful of emergency cases.\u003c/p>","reporterKeys":["afs:Reporter:2675600080"],"embedLinkURL":null,"published":"2019-02-26 16:45:01","omitFromFeed":null,"tagIds":["state-Connecticut","state-Virginia","apf-Health","YaleUniversity","Virginia","Antibiotics","apf-topnews","apf-science","apf-usnews"],"hasTextOverlay":false,"bylines":"By LAURAN NEERGAARD","language":"en-US","leadVideoId":"media:8e655b0b1e0d4bed94ca6acb32b92d45","firstWords":"\u003cp>NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa's lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a...\u003c/p>","storyHTML":"\u003cp>NEW HAVEN, Conn. (AP) — Bacteria lodged deep in Ella Balasa's lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment — deliberately inhaling a virus culled from sewage to attack her superbug.\u003c/p>\u003cp>\"I'm really running out of options,\" said Balasa, who traveled from her Richmond, Virginia, home to Yale University for the last-resort treatment. \"I know it might not have an effect. But I am very hopeful.\"\u003c/p>\u003cp>Pitting one germ against another may sound radical, but it's a sign of a growing global crisis. Increasingly people are dying of infections that once were easy to treat because many common bugs have evolved to withstand multiple antibiotics. Some, dubbed \"nightmare bacteria,\" are untreatable. Now scientists are racing to find novel alternatives to traditional antibiotics, a hunt that is uncovering unusual ways to counter infection, in unusual places.\u003c/p>\u003cdiv class=\"ad-placeholder\">\u003c/div>\u003cp>One possible treatment tricks bacteria out of a nutrient they need to survive. Others rev up the immune system to better fend off germs.\u003c/p>\u003cp>And viruses called bacteriophages — discovered a century ago but largely shelved in the West when easier-to-use antibiotics came along — are being tried in a handful of emergency cases.\u003c/p>\u003cp>\"People's frustration with antibiotic resistance boiled over,\" said Yale biologist Benjamin Chan, who travels the world collecting phages and receives calls from desperate patients asking to try them. \"We're more appreciative of the fact that we need alternatives.\"\u003c/p>\u003cdiv id='media:8e655b0b1e0d4bed94ca6acb32b92d45' class='media-placeholder'>\u003c/div>\u003cp>Nature's bacterial predator, each phage variety targets a different bacterial strain. Originally used to treat dysentery in the early 20th century, today Chan looks in places like ditches, ponds, and, yes, sewage treatment plants for types that attack a variety of human infections.\u003c/p>\u003cp>\"The best places are often really dirty places, because we're dirty animals,\" he said.\u003c/p>\u003cp>Chan saw hope for Balasa in a lab dish covered in brownish bacterial goo.\u003c/p>\u003cp>Balasa has a genetic disease called cystic fibrosis that scars her lungs and traps bacteria inside, including a superbug named Pseudomonas aeruginosa. A daily dose of inhaled antibiotics kept the infection in check until last fall, when the drugs quit working. A last-ditch IV antibiotic wasn't helping much either.\u003c/p>\u003cp>Chan grew a sample of Balasa's bacteria from her phlegm. Then came the key test: He dripped several pseudomonas-targeting phages into the grimy dish — and clear circles began appearing as the viruses consumed the bugs around them.\u003c/p>\u003cdiv class=\"ad-placeholder\">\u003c/div>\u003cp>But would what worked in the lab really help Balasa's lungs?\u003c/p>\u003cdiv id=\"media:08e2f0afebd040e5a9d0eb96873c1180\" class=\"media-placeholder\">\u003c/div>\u003cp>BUGS OUTPACING DRUGS\u003c/p>\u003cp>At least 23,000 Americans die every year as a direct result of an antibiotic-resistant infection, and many more die from related complications, according to a 2013 report from the Centers for Disease Control and Prevention. The CDC plans an updated count, but other research has estimated the toll could be seven times higher.\u003c/p>\u003cp>And while there are no good counts in much of the world, one often-cited British report said unless solutions are found, by 2050 up to 10 million people globally could be dying from drug-resistant infections, slightly more than die from cancer today.\u003c/p>\u003cdiv class=\"social-embed\" id=\"se0:1b72a920-3260-11e9-b259-d9407be5c56d\">\u003cdiv class=\"display-block\">\u003cstyle>@media only screen and (max-width: 415px){.htmlEmbedContent {width: 90%;margin: 0 auto;}}@media only screen and (min-width: 415px){.htmlEmbedContent {width: 70%;}}.youtube-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .youtube-container iframe { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }\u003c/style>\u003cdiv class=\"youtube-container\">\u003ciframe allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\" frameborder=\"0\" height=\"546\" src=\"https://www.youtube.com/embed/7mmlo7IyIxY\" width=\"971\">\u003c/iframe>\u003c/div>\u003c/div>\u003cp class=\"social-caption\">\u003c/p>\u003c/div>\u003cp>Yet few new antibiotics make it to market, and many major drug companies have ended antibiotic research, seeing little profit in medicines that germs will soon outsmart. A recent report found just 11 traditional antibiotics being studied to treat any of the World Health Organization's list of worst bugs, with no guarantee they'll work.\u003c/p>\u003cp>And while some people are more at risk — those getting surgery, or cancer chemotherapy, for example — \"antibiotic resistance is a problem essentially for everyone,\" said Dr. Anthony Fauci, infectious diseases chief at the National Institutes of Health.\u003c/p>\u003cp>\"Over the next several years, all indicators seem to point to the fact that this is going to get worse and worse,\" he added.\u003c/p>\u003cp>LOOKING FOR BUGS' WEAK SPOTS\u003c/p>\u003cp>Finding alternatives means \"figuring out what the vulnerabilities of infecting bacteria are. What do they need to cause an infection?\" said Dr. Pradeep Singh of the University of Washington.\u003c/p>\u003cp>Singh and fellow UW lung specialist Dr. Christopher Goss zeroed in on iron, a nutrient vital for bacterial growth. It turns out that bugs can't always tell the difference between iron and a chemically similar metal named gallium. Gallium doesn't nourish and knocks other systems out of whack, Goss said.\u003c/p>\u003cp>For two small studies, the researchers recruited cystic fibrosis patients who had antibiotic-resistant pseudomonas in their lungs but weren't openly sick. The patients received a five-day infusion of a gallium-based drug. Over the next few weeks, their lung function improved, enough that next-step studies are being planned.\u003c/p>\u003cdiv id=\"media:3fda999eb2db4bfa8af4d61c7723c320\" class=\"media-placeholder\">\u003c/div>\u003cp>\"It just seems like a proactive way of destroying bacteria,\" said study participant Tre LaRosa, 24, of Cincinnati. His sister died of cystic fibrosis and while his own CF is under control, he worries that one day a resistant infection will flare. \"I can't do anything to prevent that. Antibiotic resistance I think is one of the least talked about and most significant concerns.\"\u003c/p>\u003cp>SPURRING THE IMMUNE SYSTEM\u003c/p>\u003cp>Fauci envisions doctors one day vaccinating people a few weeks before, say, a planned knee replacement to guard against catching a staph infection in the hospital.\u003c/p>\u003cp>Sixteen experimental vaccines are in development to target various infections, according to a recent presentation to a presidential advisory council on resistant germs.\u003c/p>\u003cp>Particularly promising, Fauci says, are lab-engineered \"monoclonal antibodies\" designed to home in on specific bugs. In one set of studies, researchers are giving experimental antibodies to ventilator patients who have bacteria building up that could trigger pneumonia.\u003c/p>\u003cp>HARNESSING VIRUSES FOR THE BEST ATTACK\u003c/p>\u003cp>In Virginia, Balasa learned of another cystic fibrosis patient helped by Yale's phage experiments and asked to try, hoping to postpone the last option for CF, a lung transplant.\u003c/p>\u003cp>Phages work very differently than traditional antibiotics. Like a parasite, the virus infiltrates bacterial cells and uses them to copy itself, killing the bug as those copies pop out and search for more bacteria. Once the infection's gone, the virus dies out. Because each phage only recognizes certain bacteria, it shouldn't kill off \"good bugs\" in the digestive tract like antibiotics do.\u003c/p>\u003cp>Bacteria evolve to escape phages just like they escape antibiotics, but they generally make trade-offs to do so — such as losing some of their antibiotic resistance, said Yale evolutionary biologist Paul Turner.\u003c/p>\u003cdiv id=\"media:70e4faff246640a98a71f1962b96aa26\" class=\"media-placeholder\">\u003c/div>\u003cp>For example, some phages recognize bacteria by a pump on their surface that deflects antibiotics. As the phages kill those bugs, the bacteria rapidly evolve to get rid of that surface pump — meaning survivors should be susceptible to antibiotics again.\u003c/p>\u003cp>\"It's reviving an arsenal of drugs that are no longer useful,\" Turner said.\u003c/p>\u003cp>Yale's first test case was an 82-year-old man near death from a heart implant teeming with untreatable pseudomonas. Chan purified a phage from a Connecticut lake that he'd matched to the patient's germs, and with emergency permission from the Food and Drug Administration, doctors squirted it into the wound. The man's infection disappeared.\u003c/p>\u003cp>Then doctors at the University of California, San Diego, saved a colleague who'd been in a months-long coma, using an IV mixture of several phages that target a superbug named Acinetobacter baumannii.\u003c/p>\u003cp>Doctors and families began calling both centers seeking emergency care, even as formal studies are being planned to try to prove phages' value.\u003c/p>\u003cp>\"There's an incredible opportunity here,\" said Yale pulmonologist Dr. Jon Koff. \"But with that you have to have the appropriate amount of skepticism,\" with careful testing to tell when it might help.\u003c/p>\u003cp>Last month, Balasa became Yale's eighth patient, inhaling billions of phages over seven days.\u003c/p>\u003cp>Almost immediately, she was coughing up fewer bacteria. It took a few weeks for her to feel better, though, and during that time she switched briefly to some antibiotics she'd previously given up. Without a formal study it's hard to know, but Chan's tests suggest phages killed much of her predominant pseudomonas strain and made the survivors sensitive again to a course of those antibiotics.\u003c/p>\u003cp>Balasa called that \"a very big success for me,\" and was able to quit her antibiotics. She didn't notice additional improvement after a second round of phages, aimed at different strains.\u003c/p>\u003cp>\"The true test,\" Balasa said, \"is how long I can go without using any antibiotics again.\"\u003c/p>\u003cp>___\u003c/p>\u003cp>The Associated Press Health &amp; Science Department receives \u003ca href=\"http://bit.ly/2G0n9w6\">support\u003c/a> from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.\u003c/p>","leadPhotoId":"media:bb02511fe0ba40189a39b20e751ff49b"}},"loadedAt":{"urn:publicid:ap.org:b4c7e8aace4d45bca6d4b2f6b2ee0ac0":1587283833996},"expiration":120000},"medium":{"loading":{},"error":{},"data":{"media:bb02511fe0ba40189a39b20e751ff49b":{"altText":"Ella Balasa, Benjamin Chan","imageFileExtension":".jpeg","id":"media:bb02511fe0ba40189a39b20e751ff49b","embedCaption":"Ella Balasa watches Benjamin Chan pour a bacteriophagen he developed for her to inhale at the Winchester Chest Clinic in Connecticut. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and antibiotic-resistant bacteria lodged inside her CF-damaged lungs, watches as Yale University researcher Benjamin Chan, pours a bacteriophagen he developed for her to inhale, at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and antibiotic-resistant bacteria lodged inside her CF-damaged lungs, watches as Yale University researcher Benjamin Chan, pours a bacteriophagen he developed for her to inhale, at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:bb02511fe0ba40189a39b20e751ff49b/"},"media:08e2f0afebd040e5a9d0eb96873c1180":{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:08e2f0afebd040e5a9d0eb96873c1180","embedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds a petri dish containing Pseudomonas aeruginosa lung samples. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds a petri dish containing Pseudomonas aeruginosa lung samples grown from patient Ella Balasa, at Osborne Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Pitting one germ against another may sound radical, but it’s a sign of a growing global crisis. Increasingly people are dying of infections that once were easy to treat, as common bacteria evolve to resist drugs that form the foundation of modern medicine. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds a petri dish containing Pseudomonas aeruginosa lung samples grown from patient Ella Balasa, at Osborne Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Pitting one germ against another may sound radical, but it&#8217;s a sign of a growing global crisis. Increasingly people are dying of infections that once were easy to treat, as common bacteria evolve to resist drugs that form the foundation of modern medicine. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:08e2f0afebd040e5a9d0eb96873c1180/"},"media:fddef52f13b744f9b4ae5dadace6d67e":{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:fddef52f13b744f9b4ae5dadace6d67e","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:fddef52f13b744f9b4ae5dadace6d67e/"},"media:9a5dfb0813a345038de93821b32c20fc":{"altText":null,"imageFileExtension":".jpeg","id":"media:9a5dfb0813a345038de93821b32c20fc","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, prepares an antibiotic injection at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Ella Balasa, 26, of Richmond, Va., who has cystic fibrosis, and an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, prepares an antibiotic injection at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:9a5dfb0813a345038de93821b32c20fc/"},"media:daf57a871b0e4a21a5fde69cc8056261":{"altText":"Ella Balasa","imageFileExtension":".jpeg","id":"media:daf57a871b0e4a21a5fde69cc8056261","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Ella Balasa, 26, of Richmond, Va., pauses to cough as she inhales cystic fibrosis medications to help clear her airways, at Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Antibiotic-resistant bacteria are lodged inside her CF-damaged lungs. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Ella Balasa, 26, of Richmond, Va., pauses to cough as she inhales cystic fibrosis medications to help clear her airways, at Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Antibiotic-resistant bacteria are lodged inside her CF-damaged lungs. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:daf57a871b0e4a21a5fde69cc8056261/"},"media:5065213a8fae4509a0ed6e01c539b822":{"altText":"Jon Koff, Ella Balasa","imageFileExtension":".jpeg","id":"media:5065213a8fae4509a0ed6e01c539b822","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale pulmonary and critical care physician Dr. Jon Koff, talks with Ella Balasa, 26, of Richmond, Va., after her treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. She has cystic fibrosis, an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale pulmonary and critical care physician Dr. Jon Koff, talks with Ella Balasa, 26, of Richmond, Va., after her treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. She has cystic fibrosis, an antibiotic-resistant bacteria lodged inside her CF-damaged lungs, (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:5065213a8fae4509a0ed6e01c539b822/"},"media:5916930e12b1460bb883618f2fd3bbc4":{"altText":"Jon Koff, Benjamin Chan, Ella Balasa","imageFileExtension":".jpeg","id":"media:5916930e12b1460bb883618f2fd3bbc4","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale pulmonary and critical care physician Dr. Jon Koff, left, and Yale University researcher Benjamin Chan, center, watch as Ella Balasa, 26, of Richmond, Va., inhales a bacteriophage, developed by Chan, during treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Balasa has cystic fibrosis and a superbug named Pseudomonas aeruginosa is trapped in her damaged lungs. Until last fall, a daily dose of inhaled antibiotics kept it in check but suddenly, the drugs quit working. A last-ditch IV antibiotic wasn't helping much either. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale pulmonary and critical care physician Dr. Jon Koff, left, and Yale University researcher Benjamin Chan, center, watch as Ella Balasa, 26, of Richmond, Va., inhales a bacteriophage, developed by Chan, during treatment at the Winchester Chest Clinic, in New Haven, Conn., Thursday Jan. 17, 2019. Balasa has cystic fibrosis and a superbug named Pseudomonas aeruginosa is trapped in her damaged lungs. Until last fall, a daily dose of inhaled antibiotics kept it in check but suddenly, the drugs quit working. A last-ditch IV antibiotic wasn't helping much either. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:5916930e12b1460bb883618f2fd3bbc4/"},"media:70e4faff246640a98a71f1962b96aa26":{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:70e4faff246640a98a71f1962b96aa26","embedCaption":"Benjamin Chan prepares a petri dish with mucus from patient Balasa at Osborn Memorial Laboratories om Connecticut. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Chan, who travels the world collecting viruses called bacteriophages, receives calls from desperate patients asking to try them. \"We're more appreciative of the fact that we need alternatives.\" (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, prepares a petri dish with mucus from patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Chan, who travels the world collecting viruses called bacteriophages, receives calls from desperate patients asking to try them. \"We're more appreciative of the fact that we need alternatives.\" (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:70e4faff246640a98a71f1962b96aa26/"},"media:3fda999eb2db4bfa8af4d61c7723c320":{"altText":"Benjamin Chan","imageFileExtension":".jpeg","id":"media:3fda999eb2db4bfa8af4d61c7723c320","embedCaption":"\t\nYale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds bacteriophage treatment for patient Ella Balasa. (AP Photo/Richard Drew)","videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":null,"videoMimeType":null,"managementId":null,"state":null,"flattenedCaption":"Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds bacteriophage treatment for patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Bacteriophages were discovered a century ago but largely shelved when easier-to-use antibiotics came along. (AP Photo/Richard Drew)","type":"Photo","caption":"\n              \u003cp>\n              Yale University researcher Benjamin Chan, who studies viruses that attack bacteria, holds bacteriophage treatment for patient Ella Balasa, of Richmond, Va., at Osborn Memorial Laboratories, in New Haven, Conn., Thursday Jan. 17, 2019. Bacteriophages were discovered a century ago but largely shelved when easier-to-use antibiotics came along. (AP Photo/Richard Drew)\n            \u003c/p>\n            ","imageRenderedSizes":[3000,2000,1000,800,600,400],"aspectRatio":1.5,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:3fda999eb2db4bfa8af4d61c7723c320/"},"media:8e655b0b1e0d4bed94ca6acb32b92d45":{"altText":"Researchers race to find antibiotic alternatives","imageFileExtension":".jpeg","id":"media:8e655b0b1e0d4bed94ca6acb32b92d45","embedCaption":null,"videoRenderedSizes":[],"imageMimeType":"image/jpeg","etag":null,"externalId":"an9CTHD4fvE","videoMimeType":"video/mp4","managementId":"b53db9947cc2498a82f46a3d3a043a20","state":null,"flattenedCaption":"Scientists are racing to find novel ways to treat infections when traditional antibiotics fail, and they’re developing unusual approaches such as pitting one germ against another, as bacteria rapidly evolve to resist today's best medicines. (Feb. 26)","videoFileExtension":".mp4","type":"YouTube","caption":"\n              \u003cp>\n              Scientists are racing to find novel ways to treat infections when traditional antibiotics fail, and they&#8217;re developing unusual approaches such as pitting one germ against another, as bacteria rapidly evolve to resist today's best medicines. (Feb. 26)\n            \u003c/p>\n            ","imageRenderedSizes":[400],"aspectRatio":1.3333333333333333,"gcsBaseUrl":"https://storage.googleapis.com/afs-prod/media/media:8e655b0b1e0d4bed94ca6acb32b92d45/"}},"loadedAt":{"media:bb02511fe0ba40189a39b20e751ff49b":1587283833996,"media:08e2f0afebd040e5a9d0eb96873c1180":1587283833996,"media:fddef52f13b744f9b4ae5dadace6d67e":1587283833996,"media:9a5dfb0813a345038de93821b32c20fc":1587283833996,"media:daf57a871b0e4a21a5fde69cc8056261":1587283833996,"media:5065213a8fae4509a0ed6e01c539b822":1587283833997,"media:5916930e12b1460bb883618f2fd3bbc4":1587283833997,"media:70e4faff246640a98a71f1962b96aa26":1587283833997,"media:3fda999eb2db4bfa8af4d61c7723c320":1587283833997,"media:8e655b0b1e0d4bed94ca6acb32b92d45":1587283833997},"expiration":120000},"defaultTags":{"loading":{},"error":{},"data":{},"loadedAt":{},"expiration":600000},"radio":{"ignoreClickOnElements":[],"opened":false},"search":{"ignoreClickOnElements":[],"opened":false},"topics":{"ignoreClickOnElements":[],"opened":false},"headerTitle":{},"shareImage":{"loading":{"share-image":false},"error":{"share-image":null},"data":{"share-image":null},"loadedAt":{"share-image":1587283834241},"hasImage":false,"expiration":120000},"reporters":{"loading":{"afs:Reporter:2675600080":false},"error":{"afs:Reporter:2675600080":null},"data":{"afs:Reporter:2675600080":{"reporters":[]}},"loadedAt":{"afs:Reporter:2675600080":1587283834184},"expiration":120000}}
window['titanium-cacheConfig'] = {"ignoreCache":false}</script><script src="/dist/index.js?hash=1717e085f3b" async></script></body></html>